Aquavit Receives FDA Clearance for Two INDs to Initiate Clinical Trials With Its Botulinum Toxin ...Middle East

NEW YORK, April 29, 2023 /PRNewswire/ -- Aquavit Holdings (Aquavit), a biotechnology company focused on the development of botulinum toxin applications, announced today that it has received FDA clearance to initiate clinical trials for DTX-023 and DTX-024, following its submission of...

Read More Details
Finally We wish PressBee provided you with enough information of ( Aquavit Receives FDA Clearance for Two INDs to Initiate Clinical Trials With Its Botulinum Toxin )

Also on site :

• I Tried 15 Different Brands of Potato Chips and Found a New Favorite
• Putin signs new ‘made in Russia’ taxi law
• I Tried the Viral Strawberry Lobster Cake That Fans Call ‘Summer Perfection’